1. Neurocrine Biosciences, Inc.
  2. Neurocrine Biosciences, Inc. Ownership

Historical shareholding details of Los Angeles Capital Management LLC holdings in Neurocrine Biosciences, Inc. (NBIX)

Monthly changes of Los Angeles Capital Management LLC shareholding in Neurocrine Biosciences, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Los Angeles Capital Management Llc 47,135 0.05%
Feb 28, 2025 Los Angeles Capital Management Llc 55,675 0.06%
Jan 31, 2025 Los Angeles Capital Management Llc 50,131 0.05%
Dec 31, 2024 Los Angeles Capital Management Llc 512,820 0.51%
Dec 31, 2024 Los Angeles Capital Management Llc 41,591 0.04%
Nov 30, 2024 Los Angeles Capital Management Llc 41,591 0.04%
Oct 31, 2024 Los Angeles Capital Management Llc 41,591 0.04%
Sep 30, 2024 Los Angeles Capital Management Llc 420,748 0.42%
Sep 30, 2024 Los Angeles Capital Management Llc 6,738 0.01%
Aug 31, 2024 Los Angeles Capital Management Llc 6,738 0.01%
Jul 31, 2024 Los Angeles Capital Management Llc 6,738 0.01%
Jun 30, 2024 Los Angeles Capital Management Llc 56,885 0.06%
Jun 30, 2024 Los Angeles Capital Management Llc 29,918 0.03%
May 31, 2024 Los Angeles Capital Management Llc 29,918 0.03%
Apr 30, 2024 Los Angeles Capital Management Llc 71,652 0.07%
Mar 31, 2024 Los Angeles Capital Management Llc 245,381 0.24%
Mar 31, 2024 Los Angeles Capital Management Llc 71,652 0.07%
Feb 29, 2024 Los Angeles Capital Management Llc 71,652 0.07%
Jan 31, 2024 Los Angeles Capital Management Llc 71,652 0.07%
Dec 31, 2023 Los Angeles Capital Management Llc 918,391 0.91%
Dec 31, 2023 Los Angeles Capital Management Llc 40,825 0.04%
Nov 30, 2023 Los Angeles Capital Management Llc 40,825 0.04%
Oct 31, 2023 Los Angeles Capital Management Llc 40,825 0.04%
Sep 30, 2023 Los Angeles Capital Management Llc 553,405 0.56%
Sep 30, 2023 Los Angeles Capital Management Llc 41,138 0.04%
Aug 31, 2023 Los Angeles Capital Management Llc 41,138 0.04%
Jul 31, 2023 Los Angeles Capital Management Llc 41,138 0.04%
Jun 30, 2023 Los Angeles Capital Management Llc 550,598 0.56%
Jun 30, 2023 Los Angeles Capital Management Llc 47,455 0.05%
May 31, 2023 Los Angeles Capital Management Llc 47,455 0.05%
Mar 31, 2023 Los Angeles Capital Management Llc 634,845 0.65%

View all ownership details of Neurocrine Biosciences, Inc.